Clinical Trials › NCT03759522
RecruitingPhase 1
Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.
Sponsored by University of Alabama at Birmingham
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 120
Target enrollment
1
U.S. states
Feb 2019
Start date
Apr 2028
Expected completion
Interventions / Treatments
DPA-714 PET/MRI
Conditions studied
Multiple Sclerosis
Where this trial is running (1 site)
Alabama1 site
Birmingham
MS centers in Alabama
Compare treatment centers near a trial site by center type, providers and trials.
View Alabama centersMore Phase 1 trials
Browse all Phase 1 MS trialsThe app
Check out the MS Buddy app
Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.